IT & Data Management
IT & Data Management
Fluorescence Guided Surgery For Bone Cancer Patients- A Boon
Consultant Orthopaedic Oncologist and Honorary Senior Lecturer at the Newcastle University, Dr. Kenneth Rankin has decided to reunite with his fellow specialists across the Netherlands, UK, Japan, Canada, and USA to push new surgical treatment technologies in cases of...
IT & Data Management
DNA Medication Pass Is The Way Forward To Dip Side Effects
The Lancet study is the first to showcase the practical use of prescription medications based on an individual's genetic information.
The one-size-fits-all approach to pharmaceutical prescription is out of date. Patients may react differently to a specific medicine due to...
IT & Data Management
The ePI Deconstructed – A New Frontier in Patient Communication
Pharma manufacturers face several challenges when it comes to labels, both in terms of design and production. As the label size tends to increase every year, adding clarity, consistency, and appeal is becoming increasingly difficult. Pharmaceutical manufacturers also face...
IT & Data Management
Cancer Mutation Analysis Through AI- A Strong Step Forward
When single-cell data is combined with a self-learning algorithm, it is a revelation as to how structural changes can go on to trigger cancer. This new methodology can indeed pave the road for cancer treatments that are personalised in...
IT & Data Management
Aortic Stability Evaluation To Find Patients At High Risk
According to a recent study conducted in collaboration by the University of Eastern Finland and Kuopio University Hospital, patients with ascending aortic dilatation are more likely to experience pathological changes in the aortic wall when wall shear stress values...
IT & Data Management
Addressing Diseases Through Technology – A New Revolution
To grasp the intricate pathology of many diseases today, scientists and researchers have achieved amazing advances in basic science. The ability of the human mind to think critically and come up with answers is unmatched, and some of that...
IT & Data Management
5 Challenges That Will Affect Developing Biotech In 2023
Drugmakers' initial stock offerings, which had been a dependable tradition for years, mostly stopped in 2022. Fewer than two dozen biotech businesses priced initial public offerings (IPOs) last year, a 79% decrease from the total of the prior year...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















